U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07314060) titled 'A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis' on Dec. 15, 2025.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study, all subjects need to use TQH2929 injection/placebo. The aim was to demonstrate the efficacy and safety of TQH2929 injection in patients with acute exacerbations of generalized pustular psoriasis, with a total of 36 subjects.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Generalized Pustular Psoriasis
Intervention:
DRUG: TQH2929 Injections
TQH2929 is a humanized monoclonal antibo...